Are Medical Stocks Lagging Adlai Nortye Ltd. Sponsored ADR (ANL) This Year?

Group 1 - Adlai Nortye Ltd. Sponsored ADR (ANL) has returned 44.6% year-to-date, significantly outperforming the Medical sector average of 4.3% [2] - The Zacks Rank for ANL is 2 (Buy), indicating a positive earnings outlook with a 3.6% increase in the consensus estimate for full-year earnings over the past quarter [2] - ANL belongs to the Medical - Biomedical and Genetics industry, which has an average loss of 3.4% year-to-date, further highlighting ANL's strong performance [3] Group 2 - Boston Scientific (BSX) is another Medical stock that has outperformed the sector, with a year-to-date increase of 27.1% [3] - The Zacks Rank for Boston Scientific is also 2 (Buy), with a 3.1% increase in the consensus estimate for current year EPS over the past three months [3] - The Medical - Products industry, to which Boston Scientific belongs, has returned +3.3% year-to-date, ranking 145 in the Zacks Industry Rank [3]